A US Senate Health Committee hearing on 4 November on the status of the US COVID-19 response began with a reminder that acting Food and Drug Administration commissioner Janet Woodcock has strong bipartisan support as head of the agency.
The senior Republican member of the committee, North Carolina’s Richard Burr, noted there are vacancies at both the FDA and...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?